TY - CHAP
T1 - Governing AI in the European Union
T2 - Emerging Infrastructures and Regulatory Ecosystems in Health
AU - Minssen, Timo
AU - Solaiman, Barry
AU - Wested, Jakob
AU - Köttering, Lea
AU - Malik, Abeer
PY - 2024
Y1 - 2024
N2 - The European Union (EU) has been at the forefront of developing sophisticated artificial intelligence (AI) and data governance frameworks, driven by a commitment to data protection, digital rights, fundamental values and ethical standards. This chapter examines the evolving EU AI-related regulations and their potential implications for healthcare, highlighting key instruments including the Artificial Intelligence Act (AI Act), the AI Liability Directive (AILD) and the revised Product Liability Directive (revised PLD), and their intersection with AI medical devices under the Medical Device Regulation (MDR) and generative AI (GenAI). Additionally, it delves into the complex interplay between the General Data Protection Regulation (GDPR) and the AI Act, alongside an examination of the sector-specific European Health Data Space (EHDS) regulation, underscoring the need for additional instruments to govern non-personal data sharing. While the EU’s multifaceted regulatory framework aims to strike a balance between seizing the opportunities of recent AI developments and safeguarding against potential harms, challenges arise from overlapping regulations and the lack of specific healthcare focus. As these regulations come into force, systematic analyses will be imperative to fully assess their impact. Ultimately, calibrating the risks of over- and under-regulation will be a delicate task where potential trade-offs will have to be carefully considered with a keen eye on international competition and the protection of fundamental values.
AB - The European Union (EU) has been at the forefront of developing sophisticated artificial intelligence (AI) and data governance frameworks, driven by a commitment to data protection, digital rights, fundamental values and ethical standards. This chapter examines the evolving EU AI-related regulations and their potential implications for healthcare, highlighting key instruments including the Artificial Intelligence Act (AI Act), the AI Liability Directive (AILD) and the revised Product Liability Directive (revised PLD), and their intersection with AI medical devices under the Medical Device Regulation (MDR) and generative AI (GenAI). Additionally, it delves into the complex interplay between the General Data Protection Regulation (GDPR) and the AI Act, alongside an examination of the sector-specific European Health Data Space (EHDS) regulation, underscoring the need for additional instruments to govern non-personal data sharing. While the EU’s multifaceted regulatory framework aims to strike a balance between seizing the opportunities of recent AI developments and safeguarding against potential harms, challenges arise from overlapping regulations and the lack of specific healthcare focus. As these regulations come into force, systematic analyses will be imperative to fully assess their impact. Ultimately, calibrating the risks of over- and under-regulation will be a delicate task where potential trade-offs will have to be carefully considered with a keen eye on international competition and the protection of fundamental values.
UR - https://www.elgaronline.com/edcollbook-oa/book/9781802205657/9781802205657.xml
U2 - 10.4337/9781802205657.00027
DO - 10.4337/9781802205657.00027
M3 - Book chapter
SN - 9781802205640
T3 - Research Handbooks in Health and Medical Law series
SP - 311
EP - 331
BT - Research Handbook on Health, AI and the Law
A2 - Solaiman, Barry
A2 - Cohen, Glenn
PB - Edward Elgar Publishing
ER -